skip to main content
Resultados 1 2 3 4 5 next page
Mostrar Somente
Result Number Material Type Add to My Shelf Action Record Details and Options
1
High response rate with extended dosing of cemiplimab in advanced cutaneous squamous cell carcinoma
Material Type:
Artigo
Adicionar ao Meu Espaço

High response rate with extended dosing of cemiplimab in advanced cutaneous squamous cell carcinoma

Rischin, Danny ; Hughes, Brett G M ; Basset-Séguin, Nicole ; Schadendorf, Dirk ; Bowyer, Samantha ; Trabelsi Messai, Sabiha ; Meier, Friedegund ; Eigentler, Thomas K ; Casado Echarren, Victoria ; Stein, Brian ; Beylot-Barry, Marie ; Dalac, Sophie ; Dréno, Brigitte ; Migden, Michael R ; Hauschild, Axel ; Schmults, Chrysalyne D ; Lim, Annette M ; Yoo, Suk-Young ; Paccaly, Anne J ; Papachristos, Apostolos ; Nguyen, Jenny-Hoa ; Okoye, Emmanuel ; Seebach, Frank ; Booth, Jocelyn ; Lowy, Israel ; Fury, Matthew G ; Guminski, Alexander

Journal for immunotherapy of cancer, 2024-03, Vol.12 (3), p.e008325 [Periódico revisado por pares]

England: BMJ Publishing Group Ltd

Texto completo disponível

2
535 A phase I/II study of REGN7075 (EGFRxCD28 costimulatory bispecific antibody) in combination with cemiplimab (anti–PD-1) in patients with advanced solid tumors
Material Type:
Artigo
Adicionar ao Meu Espaço

535 A phase I/II study of REGN7075 (EGFRxCD28 costimulatory bispecific antibody) in combination with cemiplimab (anti–PD-1) in patients with advanced solid tumors

Lakhani, Nehal ; Johnson, Melissa ; Groisberg, Roman ; Han, Hyunsil ; Casey, Kerry ; Li, Siyu ; Skokos, Dimitris ; Seebach, Frank ; Lowy, Israel ; Fury, Matthew ; Mathias, Melissa

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A565-A565 [Periódico revisado por pares]

London: BMJ Publishing Group Ltd

Texto completo disponível

3
428 Interim analysis of Phase 2 results for cemiplimab in patients with metastatic basal cell carcinoma (mBCC) who progressed on or are intolerant to hedgehog inhibitors (HHIs)
Material Type:
Artigo
Adicionar ao Meu Espaço

428 Interim analysis of Phase 2 results for cemiplimab in patients with metastatic basal cell carcinoma (mBCC) who progressed on or are intolerant to hedgehog inhibitors (HHIs)

Lewis, Karl ; Peris, Ketty ; Sekulic, Aleksandar ; Stratigos, Alexander ; Dunn, Lara ; Eroglu, Zeynep ; Chang, Anne Lynn ; Migden, Michael ; Li, Siyu ; Mohan, Kosalai ; Coates, Ebony ; Okoye, Emmanuel ; Baurain, Jean-François ; Bechter, Oliver ; Hauschild, Axel ; Butler, Marcus ; Hernandez-Aya, Leonel ; Licitra, Lisa ; Neves, Rogerio ; Ruiz, Emily ; Seebach, Frank ; Weinreich, David ; Yancopoulos, George ; Lowy, Israel ; Bowler, Timothy ; Fury, Matthew

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A260-A261 [Periódico revisado por pares]

London: BMJ Publishing Group LTD

Texto completo disponível

4
Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial
Material Type:
Artigo
Adicionar ao Meu Espaço

Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial

Sezer, Ahmet ; Kilickap, Saadettin ; Gümüş, Mahmut ; Bondarenko, Igor ; Özgüroğlu, Mustafa ; Gogishvili, Miranda ; Turk, Haci M ; Cicin, Irfan ; Bentsion, Dmitry ; Gladkov, Oleg ; Clingan, Philip ; Sriuranpong, Virote ; Rizvi, Naiyer ; Gao, Bo ; Li, Siyu ; Lee, Sue ; McGuire, Kristina ; Chen, Chieh-I ; Makharadze, Tamta ; Paydas, Semra ; Nechaeva, Marina ; Seebach, Frank ; Weinreich, David M ; Yancopoulos, George D ; Gullo, Giuseppe ; Lowy, Israel ; Rietschel, Petra

The Lancet (British edition), 2021-02, Vol.397 (10274), p.592-604 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

5
A phase 1/2 study of REGN4336, a PSMAxCD3 bispecific antibody, alone and in combination with cemiplimab in patients with metastatic castration-resistant prostate cancer
Material Type:
Artigo
Adicionar ao Meu Espaço

A phase 1/2 study of REGN4336, a PSMAxCD3 bispecific antibody, alone and in combination with cemiplimab in patients with metastatic castration-resistant prostate cancer

Kelly, William Kevin ; Thanigaimani, Pradeep ; Sun, Furong ; Seebach, Frank A. ; Lowy, Israel ; Sandigursky, Sabina ; Miller, Elizabeth

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.TPS5105-TPS5105 [Periódico revisado por pares]

Texto completo disponível

6
Cemiplimab plus chemotherapy versus chemotherapy alone in non-small cell lung cancer: a randomized, controlled, double-blind phase 3 trial
Material Type:
Artigo
Adicionar ao Meu Espaço

Cemiplimab plus chemotherapy versus chemotherapy alone in non-small cell lung cancer: a randomized, controlled, double-blind phase 3 trial

Gogishvili, Miranda ; Melkadze, Tamar ; Makharadze, Tamta ; Giorgadze, Davit ; Dvorkin, Mikhail ; Penkov, Konstantin ; Laktionov, Konstantin ; Nemsadze, Gia ; Nechaeva, Marina ; Rozhkova, Irina ; Kalinka, Ewa ; Gessner, Christian ; Moreno-Jaime, Brizio ; Passalacqua, Rodolfo ; Li, Siyu ; McGuire, Kristina ; Kaul, Manika ; Paccaly, Anne ; Quek, Ruben G W ; Gao, Bo ; Seebach, Frank ; Weinreich, David M ; Yancopoulos, George D ; Lowy, Israel ; Gullo, Giuseppe ; Rietschel, Petra

Nature medicine, 2022-11, Vol.28 (11), p.2374-2380 [Periódico revisado por pares]

United States: Nature Publishing Group

Texto completo disponível

7
PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma
Material Type:
Artigo
Adicionar ao Meu Espaço

PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma

Migden, Michael R ; Rischin, Danny ; Schmults, Chrysalyne D ; Guminski, Alexander ; Hauschild, Axel ; Lewis, Karl D ; Chung, Christine H ; Hernandez-Aya, Leonel ; Lim, Annette M ; Chang, Anne Lynn S ; Rabinowits, Guilherme ; Thai, Alesha A ; Dunn, Lara A ; Hughes, Brett G.M ; Khushalani, Nikhil I ; Modi, Badri ; Schadendorf, Dirk ; Gao, Bo ; Seebach, Frank ; Li, Siyu ; Li, Jingjin ; Mathias, Melissa ; Booth, Jocelyn ; Mohan, Kosalai ; Stankevich, Elizabeth ; Babiker, Hani M ; Brana, Irene ; Gil-Martin, Marta ; Homsi, Jade ; Johnson, Melissa L ; Moreno, Victor ; Niu, Jiaxin ; Owonikoko, Taofeek K ; Papadopoulos, Kyriakos P ; Yancopoulos, George D ; Lowy, Israel ; Fury, Matthew G

The New England journal of medicine, 2018-07, Vol.379 (4), p.341-351 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

8
Survival with Cemiplimab in Recurrent Cervical Cancer
Material Type:
Artigo
Adicionar ao Meu Espaço

Survival with Cemiplimab in Recurrent Cervical Cancer

Tewari, Krishnansu S ; Monk, Bradley J ; Vergote, Ignace ; Miller, Austin ; de Melo, Andreia C ; Kim, Hee-Seung ; Kim, Yong Man ; Lisyanskaya, Alla ; Samouëlian, Vanessa ; Lorusso, Domenica ; Damian, Fernanda ; Chang, Chih-Long ; Gotovkin, Evgeniy A ; Takahashi, Shunji ; Ramone, Daniella ; Pikiel, Joanna ; Maćkowiak-Matejczyk, Beata ; Guerra Alía, Eva M ; Colombo, Nicoletta ; Makarova, Yulia ; Rischin, Danny ; Lheureux, Stephanie ; Hasegawa, Kosei ; Fujiwara, Keiichi ; Li, Jingjin ; Jamil, Shaheda ; Jankovic, Vladimir ; Chen, Chieh-I ; Seebach, Frank ; Weinreich, David M ; Yancopoulos, George D ; Lowy, Israel ; Mathias, Melissa ; Fury, Matthew G ; Oaknin, Ana

The New England journal of medicine, 2022-02, Vol.386 (6), p.544-555 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

9
A phase 1/2 study of REGN4336, a PSMAxCD3 bispecific antibody, alone and in combination with cemiplimab in patients with metastatic castration-resistant prostate cancer
Material Type:
Artigo
Adicionar ao Meu Espaço

A phase 1/2 study of REGN4336, a PSMAxCD3 bispecific antibody, alone and in combination with cemiplimab in patients with metastatic castration-resistant prostate cancer

Kelly, William Kevin ; Hussain, Arif ; Saraiya, Biren ; Thanigaimani, Pradeep ; Sun, Furong ; Seebach, Frank A. ; Lowy, Israel ; Sandigursky, Sabina ; Miller, Elizabeth

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.TPS284-TPS284 [Periódico revisado por pares]

Texto completo disponível

10
Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial
Material Type:
Artigo
Adicionar ao Meu Espaço

Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial

Stratigos, Alexander J ; Sekulic, Aleksandar ; Peris, Ketty ; Bechter, Oliver ; Prey, Sorilla ; Kaatz, Martin ; Lewis, Karl D ; Basset-Seguin, Nicole ; Chang, Anne Lynn S ; Dalle, Stèphane ; Orland, Almudena Fernandez ; Licitra, Lisa ; Robert, Caroline ; Ulrich, Claas ; Hauschild, Axel ; Migden, Michael R ; Dummer, Reinhard ; Li, Siyu ; Yoo, Suk-Young ; Mohan, Kosalai ; Coates, Ebony ; Jankovic, Vladimir ; Fiaschi, Nathalie ; Okoye, Emmanuel ; Bassukas, Ioannis D ; Loquai, Carmen ; De Giorgi, Vincenzo ; Eroglu, Zeynep ; Gutzmer, Ralf ; Ulrich, Jens ; Puig, Susana ; Seebach, Frank ; Thurston, Gavin ; Weinreich, David M ; Yancopoulos, George D ; Lowy, Israel ; Bowler, Timothy ; Fury, Matthew G

The lancet oncology, 2021-06, Vol.22 (6), p.848-857 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (71)
  2. Revistas revisadas por pares (76)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (77)
  2. Conjunto de Dados  (8)
  3. Anais de Congresso  (4)
  4. Book Chapters  (2)
  5. Mais opções open sub menu

Data de Publicação 

De até
  1. Antes de2001  (10)
  2. 2001Até2006  (15)
  3. 2007Até2010  (10)
  4. 2011Até2018  (14)
  5. Após 2018  (41)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (88)
  2. Alemão  (3)
  3. Japonês  (1)
  4. Mais opções open sub menu

Buscando em bases de dados remotas. Favor aguardar.